National Coverage Analysis (NCA)

Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection

CAG-00464N

Expand All | Collapse All

Contacts

Lead Analysts
Rachel Katonak
Rachel.katonak@cms.hhs.gov
410-786-8564
Lead Medical Officers
Carl Li, M.D.

History of Considerations

History Title ID
Original Consideration Preexposure Prophylaxis (PrEP) Using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection CAG-00464N You are here